Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs

Wildemberg, L. E. A. ; Neto, L. V. ; Costa, D. F. ; Nasciuti, L. E. ; Takiya, C. M. ; Alves, L. M. ; Rebora, A. ; Minuto, F. ; Ferone, D. ; Gadelha, M. R.

Journal of endocrinological investigation, 2013, Vol.36 (1), p.38-43 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível